These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 26228921)

  • 1. Adenosine A2b receptor promotes progression of human oral cancer.
    Kasama H; Sakamoto Y; Kasamatsu A; Okamoto A; Koyama T; Minakawa Y; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
    BMC Cancer; 2015 Jul; 15():563. PubMed ID: 26228921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinesin family member 4A: a potential predictor for progression of human oral cancer.
    Minakawa Y; Kasamatsu A; Koike H; Higo M; Nakashima D; Kouzu Y; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    PLoS One; 2013; 8(12):e85951. PubMed ID: 24386490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
    Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
    PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tripeptidyl peptidase II in human oral squamous cell carcinoma.
    Usukura K; Kasamatsu A; Okamoto A; Kouzu Y; Higo M; Koike H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    J Cancer Res Clin Oncol; 2013 Jan; 139(1):123-30. PubMed ID: 22986808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells.
    Ma DF; Kondo T; Nakazawa T; Niu DF; Mochizuki K; Kawasaki T; Yamane T; Katoh R
    Hum Pathol; 2010 Nov; 41(11):1550-7. PubMed ID: 20619442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin increases PDH and suppresses HIF-1α under hypoxic conditions and induces cell death in oral squamous cell carcinoma.
    Guimarães TA; Farias LC; Santos ES; de Carvalho Fraga CA; Orsini LA; de Freitas Teles L; Feltenberger JD; de Jesus SF; de Souza MG; Santos SH; de Paula AM; Gomez RS; Guimarães AL
    Oncotarget; 2016 Aug; 7(34):55057-55068. PubMed ID: 27474170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stimulatory adenosine receptor ADORA2B regulates serotonin (5-HT) synthesis and release in oxygen-depleted EC cells in inflammatory bowel disease.
    Dammen R; Haugen M; Svejda B; Alaimo D; Brenna O; Pfragner R; Gustafsson BI; Kidd M
    PLoS One; 2013; 8(4):e62607. PubMed ID: 23638125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial cell transforming sequence 2 in human oral cancer.
    Iyoda M; Kasamatsu A; Ishigami T; Nakashima D; Endo-Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    PLoS One; 2010 Nov; 5(11):e14082. PubMed ID: 21124766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.
    Saito T; Kasamatsu A; Ogawara K; Miyamoto I; Saito K; Iyoda M; Suzuki T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
    PLoS One; 2015; 10(9):e0137923. PubMed ID: 26378920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-Regulation of Nucleolar and Spindle-Associated Protein 1 (NUSAP1) Expression Suppresses Tumor and Cell Proliferation and Enhances Anti-Tumor Effect of Paclitaxel in Oral Squamous Cell Carcinoma.
    Okamoto A; Higo M; Shiiba M; Nakashima D; Koyama T; Miyamoto I; Kasama H; Kasamatsu A; Ogawara K; Yokoe H; Tanzawa H; Uzawa K
    PLoS One; 2015; 10(11):e0142252. PubMed ID: 26554377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways.
    Shimizu T; Kasamatsu A; Yamamoto A; Koike K; Ishige S; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    PLoS One; 2012; 7(9):e45510. PubMed ID: 23029062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system.
    Yoshimura S; Kasamatsu A; Nakashima D; Iyoda M; Kasama H; Saito T; Takahara T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
    Biochem Biophys Res Commun; 2017 Apr; 485(4):820-825. PubMed ID: 28257844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cavin-2 in oral cancer: A potential predictor for tumor progression.
    Unozawa M; Kasamatsu A; Higo M; Fukumoto C; Koyama T; Sakazume T; Nakashima D; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
    Mol Carcinog; 2016 Jun; 55(6):1037-47. PubMed ID: 26086332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long noncoding RNA HAS2-AS1 mediates hypoxia-induced invasiveness of oral squamous cell carcinoma.
    Zhu G; Wang S; Chen J; Wang Z; Liang X; Wang X; Jiang J; Lang J; Li L
    Mol Carcinog; 2017 Oct; 56(10):2210-2222. PubMed ID: 28485478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malic Enzyme 1 Is Associated with Tumor Budding in Oral Squamous Cell Carcinomas.
    Nakashima C; Kirita T; Yamamoto K; Mori S; Luo Y; Sasaki T; Fujii K; Ohmori H; Kawahara I; Mori T; Goto K; Kishi S; Fujiwara-Tani R; Kuniyasu H
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between the polymorphisms in exon 12 of hypoxia-inducible factor-1alpha and the clinicopathological features of oral squamous cell carcinoma.
    Shieh TM; Chang KW; Tu HF; Shih YH; Ko SY; Chen YC; Liu CJ
    Oral Oncol; 2010 Sep; 46(9):e47-53. PubMed ID: 20656543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FBLIM1 enhances oral cancer malignancy via modulation of the epidermal growth factor receptor pathway.
    Toeda Y; Kasamatsu A; Koike K; Endo-Sakamoto Y; Fushimi K; Kasama H; Yamano Y; Shiiba M; Tanzawa H; Uzawa K
    Mol Carcinog; 2018 Dec; 57(12):1690-1697. PubMed ID: 30129678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia enhances CXCR4 expression by activating HIF-1 in oral squamous cell carcinoma.
    Ishikawa T; Nakashiro K; Klosek SK; Goda H; Hara S; Uchida D; Hamakawa H
    Oncol Rep; 2009 Mar; 21(3):707-12. PubMed ID: 19212630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Persephin: A potential key component in human oral cancer progression through the RET receptor tyrosine kinase-mitogen-activated protein kinase signaling pathway.
    Baba T; Sakamoto Y; Kasamatsu A; Minakawa Y; Yokota S; Higo M; Yokoe H; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
    Mol Carcinog; 2015 Aug; 54(8):608-17. PubMed ID: 24375483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.